AMGN

2025Q4AMC

Amgen Inc primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2026-02-03 · Fiscal end 2025-12-31 · Features as of 2026-02-03

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS4.73
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move1.7%
IV front—
P/C full—
P/C front—
Features as of2026-02-03

Run-up

Close—
Ret 5d-3.6%
Ret 10d+2.3%
Ret 20d+5.6%
Ret 30d+4.4%

Post-Earnings Data

Results & reaction

Print

Actual EPS
5.29Beat
Estimated EPS4.73
Actual revenue
9.9B
Surprise %+11.8%
Beat / missBeat
Beat streak 44
Beat streak 86

Reaction

1-day stock reaction+4.0%
Implied vs actual

Implied 1.7%Actual 4.0%

Gap reaction+4.0%
Day result+8.2%
Next-day upYes
Realized / IV2.32×

Post tape

Post 5d+0.1%
Post 10d+2.5%
Post volume5.9M
Vol ×10d2.01×
Vol ×20d2.07×
Post range7.5%